Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy.

[1]  S. Chadban,et al.  Invasive Management of Coronary Artery Disease in Advanced Renal Disease , 2021, Kidney international reports.

[2]  D. Leaf,et al.  Soluble Urokinase Receptor and Acute Kidney Injury. , 2020, The New England journal of medicine.

[3]  H. Krumholz,et al.  Development and Validation of a Model for Predicting the Risk of Acute Kidney Injury Associated With Contrast Volume Levels During Percutaneous Coronary Intervention , 2019, JAMA network open.

[4]  L. Newby,et al.  Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[5]  Z. Ali,et al.  Zero‐contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6]  C. Ronco,et al.  Volume expansion and contrast-induced acute kidney injury , 2017, The Lancet.

[7]  A. Patzak,et al.  Understanding and preventing contrast-induced acute kidney injury , 2017, Nature Reviews Nephrology.

[8]  G. Stone,et al.  Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. , 2016, European heart journal.

[9]  Z. Ali,et al.  Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administration. , 2016, European heart journal.

[10]  C. Guenancia,et al.  N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. , 2015, The American journal of cardiology.

[11]  Junzhou Fu,et al.  Neutrophil Gelatinase-associated Lipocalin in the Prediction of Contrast-induced Nephropathy: A Systemic Review and Meta-analysis , 2015, Journal of cardiovascular pharmacology.

[12]  Lichuan Yang,et al.  Novel risk score of contrast‐induced nephropathy after percutaneous coronary intervention , 2015, Nephrology.

[13]  M. Velázquez,et al.  Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. , 2015, The American journal of cardiology.

[14]  J. Coresh,et al.  Explaining the racial difference in AKI incidence. , 2014, Journal of the American Society of Nephrology : JASN.

[15]  M. Tonelli,et al.  KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. , 2014, Kidney international.

[16]  Somjot S. Brar,et al.  Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial , 2014, The Lancet.

[17]  R. Solomon.  Contrast Media: Are There Differences in Nephrotoxicity among Contrast Media? , 2014, BioMed research international.

[18]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[19]  Peter L Duffy,et al.  Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study , 2013, The Lancet.

[20]  S. Weisbord,et al.  Contrast-induced acute kidney injury: short- and long-term implications. , 2011, Seminars in nephrology.

[21]  Deepak L. Bhatt,et al.  The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. , 2008, American heart journal.

[22]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[23]  U. Varol,et al.  Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  Charles Davidson,et al.  Risk prediction of contrast-induced nephropathy. , 2006, The American journal of cardiology.

[25]  R. Mehran,et al.  Contrast-induced nephropathy: definition, epidemiology, and patients at risk. , 2006, Kidney international. Supplement.

[26]  F. Veglia,et al.  Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[27]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[28]  R. Bersin,et al.  Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.

[29]  S. Hou,et al.  Hospital-acquired renal insufficiency. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  W. O’Neill,et al.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.

[31]  B. Barrett,et al.  Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. , 1993, Radiology.

[32]  G. Dangas,et al.  Contrast‐induced nephropathy , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[33]  P. McCullough,et al.  Epidemiology of contrast-induced nephropathy. , 2003, Reviews in cardiovascular medicine.

[34]  Deeb N Salem,et al.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. , 2003, Journal of the American College of Cardiology.

[35]  H. S. Thomsen,et al.  Contrast-media-induced nephrotoxicity: a consensus report , 1999, European Radiology.

[36]  E. Halpern,et al.  Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. , 1995, Kidney international.

[37]  G. Berlyne,et al.  Acute renal failure following intravenous pyelography with hypaque. , 1962, Acta Medica Scandinavica.